DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE:Q) announced today
the pricing of an underwritten, secondary public offering of 10,571,003
shares of its common stock by certain of its existing stockholders,
including affiliates of TPG Global, LLC, CPP Investment Board Private
Holdings, Inc., investment funds associated with Bain Capital Investors,
LLC, Leonard Green & Partners, L.P., and Dr. Dennis B. Gillings, CBE and
certain of his affiliates (the “Selling Stockholders”). QuintilesIMS
intends to repurchase from the underwriter a number of shares having an
aggregate value of approximately $300 million (the “Repurchase”).
QuintilesIMS is not offering any stock in this transaction and will not
receive any proceeds from the sale of the shares by the Selling
Stockholders in the offering. QuintilesIMS’s per-share purchase price
for the repurchased shares will be the same as the per-share purchase
price payable by the underwriter to the Selling Stockholders.
QuintilesIMS expects to fund the Repurchase with cash on hand and
borrowings from its revolving credit facility. The Repurchase is subject
to completion of the offering.
Morgan Stanley is acting as the sole underwriter for the offering. The
shares will be offered from time to time in one or more transactions on
the New York Stock Exchange, in the over-the-counter market, through
negotiated transactions or otherwise at prices prevailing at the time of
sale, at prices related to prevailing prices or at negotiated prices.
The offering is expected to close on May 31, 2017, subject to customary
closing conditions.
An automatic shelf registration statement (including a prospectus)
relating to the offering of common stock was filed with the Securities
and Exchange Commission (SEC) on May 24, 2017, and became effective upon
filing. Before you invest, you should read the registration statement,
prospectus and other documents QuintilesIMS has made available with the
SEC for information about QuintilesIMS and the offering. You may obtain
these documents free of charge by visiting EDGAR on the SEC website at www.sec.gov.
Alternatively, copies of the prospectus and accompanying prospectus
supplement may be obtained from: Morgan Stanley & Co. LLC, Attention:
Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York
10014.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy these securities, nor shall there be any
sale of these securities in any state or other jurisdiction in which
such an offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or other jurisdiction.
About QuintilesIMS
QuintilesIMS (NYSE:Q) is a leading integrated information and
technology-enabled healthcare service provider worldwide, dedicated to
helping its clients improve their clinical, scientific and commercial
results. Formed through the merger of Quintiles Transnational Holdings
Inc. and IMS Health Holdings, Inc., QuintilesIMS’s approximately 50,000
employees conduct operations in more than 100 countries. Companies
seeking to improve real-world patient outcomes through treatment
innovations, care provision and access can leverage QuintilesIMS’s broad
range of healthcare information, technology and service solutions to
drive new insights and approaches. QuintilesIMS provides solutions that
span clinical to commercial, bringing customers a unique opportunity to
realize the full potential of innovations and advanced healthcare
outcomes.
QUINTILESIMSFIN
Click
here to subscribe to Mobile Alerts for QuintilesIMS.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170525005509/en/
Source: Quintiles IMS Holdings, Inc.